USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR PREPARING A PHARMACEUTICAL COMPOSITION INTENDED FOR THE TREATMENT OF PRIMARY CANCERS OF THE PLEURA

摘要

The use of a polypeptide (I) with human interleukin 2 activity is claimed for treating primary cancers of the pleura, especially mesothelioma. Pref. (I) is a pure recombinant IL-2, especially in the non-glycosylated reduced form.